New insights into the pathophysiology and development of novel therapies for sickle cell disease
S Moerdler, D Manwani - Hematology 2014, the American …, 2018 - ashpublications.org
Although the seminal event in sickle cell disease is the polymerization of abnormal
hemoglobin, the downstream pathophysiology of vasoocclusion results from heterotypic …
hemoglobin, the downstream pathophysiology of vasoocclusion results from heterotypic …
Biochemical and therapeutic effects of omega-3 fatty acids in sickle cell disease
AA Daak, MA Lopez-Toledano, MM Heeney - Complementary Therapies in …, 2020 - Elsevier
Sickle cell disease (SCD) is a hematologic disorder with complex pathophysiology that
includes chronic hemolysis, vaso-occlusion and inflammation. Increased leukocyte …
includes chronic hemolysis, vaso-occlusion and inflammation. Increased leukocyte …
[HTML][HTML] Effect of omega-3 (n− 3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial
AA Daak, K Ghebremeskel, Z Hassan, B Attallah… - The American journal of …, 2013 - Elsevier
Background: Blood cell aggregation and adherence to vascular endothelium and
inflammation play a central role in vaso-occlusive crisis in sickle cell disease. The …
inflammation play a central role in vaso-occlusive crisis in sickle cell disease. The …
[HTML][HTML] Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease
The anemia of sickle cell disease is associated with a severe inflammatory vasculopathy
and endothelial dysfunction, which leads to painful and life-threatening clinical …
and endothelial dysfunction, which leads to painful and life-threatening clinical …
[PDF][PDF] State of the art paper Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects
AFG Cicero, A Reggi, A Parini, C Borghi - Archives of Medical Science, 2012 - termedia.pl
Abstract n-3 Polyunsaturated fatty acids (PUFAs) are organic acids, essential for mammals,
whose deficiency is associated with different diseases. The American Heart Association …
whose deficiency is associated with different diseases. The American Heart Association …
Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)
AA Daak, CD Dampier, B Fuh, J Kanter… - Blood …, 2018 - ashpublications.org
Blood cell membranes in sickle cell disease (SCD) have low docosahexaenoic acid (DHA).
DHA treatment reduces sickle cell crisis (SCC) rate and ameliorates the inflammation …
DHA treatment reduces sickle cell crisis (SCC) rate and ameliorates the inflammation …
Omega 3 (n− 3) fatty acids down-regulate nuclear factor-kappa B (NF-κB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell …
AA Daak, AY Elderdery, LM Elbashir… - Blood Cells, Molecules …, 2015 - Elsevier
Chronic inflammation and reduced blood levels of omega-3 fatty acids (n− 3) are known
characteristics of sickle cell disease (SCD). The anti-inflammatory properties of n− 3 fatty …
characteristics of sickle cell disease (SCD). The anti-inflammatory properties of n− 3 fatty …
[HTML][HTML] Dietary alpha‐linolenic acid reduces platelet activation and collagen‐mediated cell adhesion in sickle cell disease mice
S Stivala, S Gobbato, N Bonetti, GG Camici… - Journal of Thrombosis …, 2022 - Elsevier
Background Sickle cell disease (SCD) is a genetic hemoglobinopathy associated with high
morbidity and mortality. The primary cause of hospitalization in SCD is vaso‐occlusive crisis …
morbidity and mortality. The primary cause of hospitalization in SCD is vaso‐occlusive crisis …
Precipitating factors and targeted therapies in combating the perils of sickle cell disease---A special nutritional consideration
Nutritional research in sickle cell disease has been the focus in recent times owing to not
only specific nutritional deficiencies, but also the improvements associated with less painful …
only specific nutritional deficiencies, but also the improvements associated with less painful …
Antioxidant vitamins C and E supplementation increases markers of haemolysis in sickle cell anaemia patients: a randomized, double‐blind, placebo‐controlled trial
MM Arruda, G Mecabo, CA Rodrigues… - British journal of …, 2013 - Wiley Online Library
Erythrocytes from sickle cell anaemia (SCA) patients continuously produce larger amounts
of pro‐oxidants than normal cells. Oxidative stress seems to primarily affect the membrane …
of pro‐oxidants than normal cells. Oxidative stress seems to primarily affect the membrane …